| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.24e-05 | 231 | 93 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TRIO KALRN MYCBP2 TAGAP FRMD7 DOCK7 GBP3 GIT2 RAPGEF2 TBC1D9 SPATA13 | 2.37e-05 | 507 | 93 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TRIO KALRN MYCBP2 TAGAP FRMD7 DOCK7 GBP3 GIT2 RAPGEF2 TBC1D9 SPATA13 | 2.37e-05 | 507 | 93 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 3.91e-05 | 41 | 93 | 4 | GO:0000217 | |
| GeneOntologyMolecularFunction | four-way junction DNA binding | 8.98e-05 | 19 | 93 | 3 | GO:0000400 | |
| GeneOntologyMolecularFunction | transition metal ion binding | BLM ZDHHC15 ZFHX4 MYCBP2 RBBP6 DCP2 DNAJC21 APLP2 KDM4A CHD3 CHD4 MDM2 TRIM24 F8 TRIP4 ZBBX | 1.12e-04 | 1189 | 93 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.22e-04 | 21 | 93 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.24e-04 | 262 | 93 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | zinc ion binding | BLM ZDHHC15 ZFHX4 MYCBP2 RBBP6 DNAJC21 KDM4A CHD3 CHD4 MDM2 TRIM24 TRIP4 ZBBX | 2.42e-04 | 891 | 93 | 13 | GO:0008270 |
| GeneOntologyMolecularFunction | D-loop DNA binding | 3.18e-04 | 6 | 93 | 2 | GO:0062037 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 3.18e-04 | 6 | 93 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.20e-04 | 127 | 93 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | 5'-flap endonuclease activity | 4.44e-04 | 7 | 93 | 2 | GO:0017108 | |
| GeneOntologyMolecularFunction | flap endonuclease activity | 5.90e-04 | 8 | 93 | 2 | GO:0048256 | |
| GeneOntologyMolecularFunction | chromatin binding | PPARGC1A TNRC18 SUPT16H EXO1 CHD3 CHD4 SMARCAD1 MED1 FANCM TRIM24 JMJD1C | 6.39e-04 | 739 | 93 | 11 | GO:0003682 |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 6.78e-04 | 37 | 93 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | helicase activity | 8.64e-04 | 158 | 93 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.28e-03 | 46 | 93 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.47e-03 | 360 | 93 | 7 | GO:0051020 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.82e-03 | 187 | 93 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | endodeoxyribonuclease activity, producing 5'-phosphomonoesters | 1.88e-03 | 14 | 93 | 2 | GO:0016888 | |
| GeneOntologyMolecularFunction | histone H3K9 demethylase activity | 1.88e-03 | 14 | 93 | 2 | GO:0032454 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.94e-03 | 53 | 93 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | TRIO KALRN MYCBP2 GPR158 TAGAP FRMD7 DBNL DOCK7 GBP3 APLP2 NCF2 GIT2 RAPGEF2 TBC1D9 SPATA13 | 2.24e-03 | 1418 | 93 | 15 | GO:0030234 |
| GeneOntologyMolecularFunction | diacylglycerol-dependent serine/threonine kinase activity | 2.47e-03 | 16 | 93 | 2 | GO:0004697 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 2.47e-03 | 16 | 93 | 2 | GO:0043138 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 3.12e-03 | 645 | 93 | 9 | GO:0140640 | |
| GeneOntologyMolecularFunction | 5'-3' exonuclease activity | 3.13e-03 | 18 | 93 | 2 | GO:0008409 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.34e-03 | 417 | 93 | 7 | GO:0061629 | |
| GeneOntologyBiologicalProcess | neuron projection development | FBXO38 ZDHHC15 FAT4 MRTFB DST TRIO KALRN MYCBP2 FRMD7 PPP1R9A DBNL DOCK7 MPDZ APLP2 PRKCZ RAPGEF2 MDM2 PIP5K1C | 1.27e-05 | 1285 | 92 | 18 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ZDHHC15 FAT1 DST TRIO KALRN MYCBP2 PPP1R9A DBNL DOCK7 APLP2 PRKCZ MED1 RAPGEF2 PIP5K1C JMJD1C PACSIN2 | 7.03e-05 | 1194 | 92 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | FBXO38 ZDHHC15 FAT4 MRTFB DST TRIO KALRN MYCBP2 FRMD7 PPP1R9A DBNL DOCK7 MPDZ APLP2 PRKCZ RAPGEF2 MDM2 PIP5K1C | 7.05e-05 | 1463 | 92 | 18 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ZDHHC15 DST TRIO KALRN MYCBP2 PPP1R9A DBNL DOCK7 APLP2 PRKCZ RAPGEF2 PIP5K1C PACSIN2 | 7.44e-05 | 826 | 92 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | replication fork processing | 8.52e-05 | 52 | 92 | 4 | GO:0031297 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient | 1.06e-04 | 55 | 92 | 4 | GO:0031670 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | ABCA1 TRIO KALRN TAGAP FRMD7 DBNL DOCK7 GIT2 RAPGEF2 SPATA13 | 1.42e-04 | 538 | 92 | 10 | GO:0007264 |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication maintenance of fidelity | 1.49e-04 | 60 | 92 | 4 | GO:0045005 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine morphogenesis | 1.92e-04 | 64 | 92 | 4 | GO:0061001 | |
| GeneOntologyBiologicalProcess | response to camptothecin | 1.95e-04 | 5 | 92 | 2 | GO:1901563 | |
| GeneOntologyBiologicalProcess | cellular response to camptothecin | 1.95e-04 | 5 | 92 | 2 | GO:0072757 | |
| GeneOntologyBiologicalProcess | double-strand break repair via homologous recombination | 1.97e-04 | 188 | 92 | 6 | GO:0000724 | |
| GeneOntologyBiologicalProcess | cell junction assembly | DST MYCBP2 PPP1R9A DBNL DOCK7 MPDZ PKN2 CHD4 RAPGEF2 PIP5K1C | 2.24e-04 | 569 | 92 | 10 | GO:0034329 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ZDHHC15 DST TRIO KALRN MYCBP2 PPP1R9A DBNL DOCK7 APLP2 PRKCZ RAPGEF2 PIP5K1C | 2.30e-04 | 802 | 92 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | recombinational repair | 2.34e-04 | 194 | 92 | 6 | GO:0000725 | |
| GeneOntologyBiologicalProcess | DNA recombination | 2.40e-04 | 368 | 92 | 8 | GO:0006310 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ZDHHC15 DST TRIO KALRN MYCBP2 PPP1R9A DBNL DOCK7 APLP2 PRKCZ RAPGEF2 PIP5K1C | 2.78e-04 | 819 | 92 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | resolution of DNA recombination intermediates | 2.92e-04 | 6 | 92 | 2 | GO:0071139 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 3.37e-04 | 387 | 92 | 8 | GO:0050807 | |
| GeneOntologyBiologicalProcess | cellular response to vitamin | 3.53e-04 | 31 | 92 | 3 | GO:0071295 | |
| GeneOntologyBiologicalProcess | cellular response to ionizing radiation | 3.72e-04 | 76 | 92 | 4 | GO:0071479 | |
| GeneOntologyBiologicalProcess | cell junction organization | ZDHHC15 DST KALRN MYCBP2 GPR158 PPP1R9A DBNL DOCK7 MPDZ PKN2 CHD4 RAPGEF2 PIP5K1C | 3.75e-04 | 974 | 92 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 3.86e-04 | 395 | 92 | 8 | GO:0050803 | |
| GeneOntologyBiologicalProcess | ribosome-associated ubiquitin-dependent protein catabolic process | 4.07e-04 | 7 | 92 | 2 | GO:1990116 | |
| GeneOntologyBiologicalProcess | nuclear migration | 4.65e-04 | 34 | 92 | 3 | GO:0007097 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 4.74e-04 | 81 | 92 | 4 | GO:0060997 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ZDHHC15 DST TRIO KALRN MYCBP2 PPP1R9A DBNL DOCK7 APLP2 RAPGEF2 PIP5K1C | 4.92e-04 | 748 | 92 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | replication-born double-strand break repair via sister chromatid exchange | 5.41e-04 | 8 | 92 | 2 | GO:1990414 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 5.51e-04 | 36 | 92 | 3 | GO:1904754 | |
| GeneOntologyBiologicalProcess | double-strand break repair | 6.19e-04 | 324 | 92 | 7 | GO:0006302 | |
| GeneOntologyCellularComponent | asymmetric synapse | ZDHHC15 DST KALRN GPR158 PPP1R9A DBNL RNF10 MPDZ CHD4 PRKCZ PIP5K1C | 7.92e-06 | 477 | 92 | 11 | GO:0032279 |
| GeneOntologyCellularComponent | neuron to neuron synapse | ZDHHC15 DST KALRN GPR158 PPP1R9A DBNL RNF10 MPDZ CHD4 PRKCZ PIP5K1C | 1.87e-05 | 523 | 92 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | anchoring junction | FAT1 IGF2R DST FHOD1 DBNL DOCK7 MPDZ PCDHA10 PKN2 PRKCZ GIT2 RAPGEF2 LCP2 PIP5K1C PACSIN2 | 2.21e-05 | 976 | 92 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | postsynaptic density | ZDHHC15 DST KALRN GPR158 PPP1R9A DBNL RNF10 MPDZ PRKCZ PIP5K1C | 2.94e-05 | 451 | 92 | 10 | GO:0014069 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PACS1 FAT1 ABCA1 IGF2R DST KALRN GBP3 CACNA1G PKN2 LTBP1 PRKCZ RAPGEF2 CMYA5 TRIP10 | 5.61e-05 | 934 | 92 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | cell-cell junction | FAT1 DST FHOD1 MPDZ PCDHA10 PKN2 PRKCZ RAPGEF2 LCP2 PIP5K1C PACSIN2 | 5.69e-05 | 591 | 92 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic specialization | ZDHHC15 DST KALRN GPR158 PPP1R9A DBNL RNF10 MPDZ PRKCZ PIP5K1C | 7.34e-05 | 503 | 92 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | postsynapse | ZDHHC15 KCNA3 DST TRIO KALRN GPR158 PPP1R9A DBNL RNF10 MPDZ APLP2 PRKCZ RAPGEF2 PIP5K1C | 1.40e-04 | 1018 | 92 | 14 | GO:0098794 |
| GeneOntologyCellularComponent | cell leading edge | 3.57e-04 | 500 | 92 | 9 | GO:0031252 | |
| GeneOntologyCellularComponent | nuclear body | BLM CREBRF PPARGC1A RBBP6 EXO1 PKN2 CHD3 CMYA5 MDM2 UBASH3A TRIP4 PACSIN2 | 5.92e-04 | 903 | 92 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | chromatin | PPARGC1A RAD51AP1 FANCB ZFHX4 MLX PHF20L1 SUPT16H KDM4A CHD3 CHD4 SMARCAD1 MED1 RFX7 FANCM TRIM24 JMJD1C | 6.86e-04 | 1480 | 92 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | glutamatergic synapse | KCNA3 TRIO KALRN PPP1R9A DBNL RNF10 MPDZ CHD4 PRKCZ PIP5K1C PACSIN2 | 9.13e-04 | 817 | 92 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | Fanconi anaemia nuclear complex | 1.94e-03 | 15 | 92 | 2 | GO:0043240 | |
| MousePheno | abnormal gastrocnemius morphology | 1.92e-05 | 27 | 84 | 4 | MP:0003082 | |
| MousePheno | decreased gastrocnemius weight | 4.43e-05 | 12 | 84 | 3 | MP:0009422 | |
| Domain | SH3 | 1.56e-06 | 216 | 95 | 9 | PS50002 | |
| Domain | SH3_domain | 1.81e-06 | 220 | 95 | 9 | IPR001452 | |
| Domain | SH3_1 | 1.89e-06 | 164 | 95 | 8 | PF00018 | |
| Domain | SH3 | 1.44e-05 | 216 | 95 | 8 | SM00326 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.91e-05 | 35 | 95 | 4 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 4.06e-05 | 38 | 95 | 4 | PS00690 | |
| Domain | CHD_N | 7.65e-05 | 3 | 95 | 2 | IPR012958 | |
| Domain | CHD_C2 | 7.65e-05 | 3 | 95 | 2 | IPR012957 | |
| Domain | CHDCT2 | 7.65e-05 | 3 | 95 | 2 | PF08074 | |
| Domain | CHDNT | 7.65e-05 | 3 | 95 | 2 | PF08073 | |
| Domain | DUF1086 | 7.65e-05 | 3 | 95 | 2 | IPR009462 | |
| Domain | DUF1087 | 7.65e-05 | 3 | 95 | 2 | IPR009463 | |
| Domain | DUF1087 | 7.65e-05 | 3 | 95 | 2 | PF06465 | |
| Domain | DUF1086 | 7.65e-05 | 3 | 95 | 2 | PF06461 | |
| Domain | DUF1087 | 7.65e-05 | 3 | 95 | 2 | SM01147 | |
| Domain | DUF1086 | 7.65e-05 | 3 | 95 | 2 | SM01146 | |
| Domain | - | 9.52e-05 | 449 | 95 | 10 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.14e-04 | 459 | 95 | 10 | IPR013083 | |
| Domain | ZF_PHD_1 | 1.30e-04 | 96 | 95 | 5 | PS01359 | |
| Domain | XPG_I | 1.53e-04 | 4 | 95 | 2 | PF00867 | |
| Domain | XPG-I_dom | 1.53e-04 | 4 | 95 | 2 | IPR006086 | |
| Domain | XPG/Rad2 | 1.53e-04 | 4 | 95 | 2 | IPR006084 | |
| Domain | HhH2 | 1.53e-04 | 4 | 95 | 2 | IPR008918 | |
| Domain | 5-3_exonuclease_C | 1.53e-04 | 4 | 95 | 2 | IPR020045 | |
| Domain | XPG_1 | 1.53e-04 | 4 | 95 | 2 | PS00841 | |
| Domain | XPG_2 | 1.53e-04 | 4 | 95 | 2 | PS00842 | |
| Domain | HhH2 | 1.53e-04 | 4 | 95 | 2 | SM00279 | |
| Domain | XPGN | 1.53e-04 | 4 | 95 | 2 | SM00485 | |
| Domain | XPGI | 1.53e-04 | 4 | 95 | 2 | SM00484 | |
| Domain | RING | 1.64e-04 | 305 | 95 | 8 | SM00184 | |
| Domain | Spectrin | 2.10e-04 | 23 | 95 | 3 | PF00435 | |
| Domain | Helicase_C | 2.16e-04 | 107 | 95 | 5 | PF00271 | |
| Domain | HELICc | 2.16e-04 | 107 | 95 | 5 | SM00490 | |
| Domain | Helicase_C | 2.26e-04 | 108 | 95 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 2.36e-04 | 109 | 95 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.36e-04 | 109 | 95 | 5 | PS51192 | |
| Domain | DEXDc | 2.36e-04 | 109 | 95 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.46e-04 | 110 | 95 | 5 | IPR014001 | |
| Domain | XPG_DNA_repair_N | 2.53e-04 | 5 | 95 | 2 | IPR006085 | |
| Domain | XPG_N | 2.53e-04 | 5 | 95 | 2 | PF00752 | |
| Domain | Znf_RING | 2.57e-04 | 326 | 95 | 8 | IPR001841 | |
| Domain | Zinc_finger_PHD-type_CS | 3.35e-04 | 65 | 95 | 4 | IPR019786 | |
| Domain | Spectrin_repeat | 4.23e-04 | 29 | 95 | 3 | IPR002017 | |
| Domain | SNF2_N | 5.68e-04 | 32 | 95 | 3 | IPR000330 | |
| Domain | SNF2_N | 5.68e-04 | 32 | 95 | 3 | PF00176 | |
| Domain | SPEC | 5.68e-04 | 32 | 95 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.68e-04 | 32 | 95 | 3 | IPR018159 | |
| Domain | TB_dom | 9.00e-04 | 9 | 95 | 2 | IPR017878 | |
| Domain | TB | 9.00e-04 | 9 | 95 | 2 | PS51364 | |
| Domain | Znf_FYVE_PHD | 9.26e-04 | 147 | 95 | 5 | IPR011011 | |
| Domain | PHD | 1.10e-03 | 89 | 95 | 4 | SM00249 | |
| Domain | Znf_PHD | 1.20e-03 | 91 | 95 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.40e-03 | 95 | 95 | 4 | PS50016 | |
| Domain | - | 1.63e-03 | 12 | 95 | 2 | 3.40.50.1010 | |
| Domain | PB1 | 2.24e-03 | 14 | 95 | 2 | SM00666 | |
| Domain | PIN_domain-like | 2.24e-03 | 14 | 95 | 2 | IPR029060 | |
| Domain | PB1 | 2.24e-03 | 14 | 95 | 2 | PF00564 | |
| Domain | PB1 | 2.24e-03 | 14 | 95 | 2 | PS51745 | |
| Domain | PB1_dom | 2.24e-03 | 14 | 95 | 2 | IPR000270 | |
| Domain | Cadherin_CS | 2.32e-03 | 109 | 95 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 2.65e-03 | 113 | 95 | 4 | PS00232 | |
| Domain | Cadherin | 2.65e-03 | 113 | 95 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 2.74e-03 | 114 | 95 | 4 | PS50268 | |
| Domain | - | 2.74e-03 | 114 | 95 | 4 | 2.60.40.60 | |
| Domain | CA | 2.82e-03 | 115 | 95 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.91e-03 | 116 | 95 | 4 | IPR015919 | |
| Domain | Cadherin | 3.10e-03 | 118 | 95 | 4 | IPR002126 | |
| Domain | ZF_RING_1 | 3.71e-03 | 291 | 95 | 6 | PS00518 | |
| Domain | DH_1 | 4.06e-03 | 63 | 95 | 3 | PS00741 | |
| Domain | ZF_RING_2 | 4.16e-03 | 298 | 95 | 6 | PS50089 | |
| Domain | UBA-like | 4.24e-03 | 64 | 95 | 3 | IPR009060 | |
| Domain | RhoGEF | 5.03e-03 | 68 | 95 | 3 | SM00325 | |
| Domain | CRAL_TRIO | 5.05e-03 | 21 | 95 | 2 | PF00650 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DST TRIO KALRN TAGAP RBBP6 DOCK7 NCF2 PKN2 GIT2 COPS2 TRIP10 SPATA13 | 2.35e-06 | 439 | 73 | 12 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DST TRIO KALRN TAGAP RBBP6 DOCK7 NCF2 PKN2 GIT2 COPS2 TRIP10 SPATA13 | 3.04e-06 | 450 | 73 | 12 | M27078 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 3.25e-06 | 175 | 73 | 8 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 4.72e-06 | 184 | 73 | 8 | M41809 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DST TRIO KALRN TAGAP RBBP6 DOCK7 NCF2 PKN2 PRKCZ GIT2 COPS2 TRIP10 SPATA13 | 2.49e-05 | 649 | 73 | 13 | MM15690 |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 3.07e-05 | 35 | 73 | 4 | MM15293 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES | 3.84e-05 | 37 | 73 | 4 | M27583 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DST TRIO KALRN TAGAP RBBP6 DOCK7 NCF2 PKN2 PRKCZ GIT2 COPS2 TRIP10 SPATA13 | 7.28e-05 | 720 | 73 | 13 | M41838 |
| Pathway | REACTOME_DNA_REPAIR | 1.59e-04 | 301 | 73 | 8 | MM15433 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.60e-04 | 157 | 73 | 6 | MM15226 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY | 1.77e-04 | 160 | 73 | 6 | M27498 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 2.43e-04 | 59 | 73 | 4 | MM15283 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.49e-04 | 24 | 73 | 3 | M13404 | |
| Pathway | REACTOME_DNA_REPAIR | 3.09e-04 | 332 | 73 | 8 | M15434 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 3.18e-04 | 26 | 73 | 3 | MM15297 | |
| Pathway | REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA | 3.56e-04 | 27 | 73 | 3 | M27586 | |
| Pathway | REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR | 4.69e-04 | 70 | 73 | 4 | M27570 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION | 5.40e-04 | 31 | 73 | 3 | M48258 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.46e-04 | 7 | 73 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 7.26e-04 | 8 | 73 | 2 | M22058 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 8.38e-04 | 142 | 73 | 5 | MM15499 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 9.20e-04 | 145 | 73 | 5 | M27753 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 9.49e-04 | 146 | 73 | 5 | MM15292 | |
| Pathway | PID_RAC1_REG_PATHWAY | 9.87e-04 | 38 | 73 | 3 | M241 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.24e-03 | 155 | 73 | 5 | M41808 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 1.31e-03 | 92 | 73 | 4 | MM15338 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 1.31e-03 | 92 | 73 | 4 | M27636 | |
| Pathway | REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE | 1.42e-03 | 43 | 73 | 3 | M27588 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.42e-03 | 94 | 73 | 4 | MM15598 | |
| Pubmed | IGF2R KCNA3 DST TRIO KALRN MYCBP2 GPR158 KIF21A PPP1R9A SUPT16H DOCK7 MPDZ CHD4 GIT2 RAPGEF2 SLC4A4 PCM1 SPATA13 | 1.17e-10 | 963 | 95 | 18 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BLM FBXO38 PACS1 MYCBP2 RBBP6 FHOD1 USP24 EXO1 PKN2 CHD3 CHD4 SMARCAD1 MED1 RFX7 PCM1 TBC1D9 | 3.34e-10 | 774 | 95 | 16 | 15302935 |
| Pubmed | 1.14e-09 | 18 | 95 | 5 | 7776974 | ||
| Pubmed | MRTFB DST ZFHX4 MYCBP2 USP24 DOCK7 CHD3 CHD4 LRBA TRIM24 JMJD1C PCM1 | 1.73e-09 | 418 | 95 | 12 | 34709266 | |
| Pubmed | MRTFB MYCBP2 RBBP6 DBNL USP24 DOCK7 MPDZ RPRD2 PKN2 LRBA MED1 JMJD1C PCM1 | 3.52e-09 | 549 | 95 | 13 | 38280479 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | BLM FBXO38 RAD51AP1 PHF20L1 SUPT16H KDM4A CHD3 CHD4 SMARCAD1 MED1 TRIM24 JMJD1C ZNF292 | 1.18e-08 | 608 | 95 | 13 | 36089195 |
| Pubmed | DST MLX TRIO KALRN MYCBP2 SUPT16H RNF10 CHD4 GIT2 CMYA5 MDM2 JMJD1C | 1.19e-08 | 497 | 95 | 12 | 23414517 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NHSL1 DST TRIO MYCBP2 DCP2 DBNL DOCK7 RNF10 EXO1 MPDZ RAPGEF2 RFX7 GEN1 PCM1 SPATA13 | 1.25e-08 | 861 | 95 | 15 | 36931259 |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 5.12e-08 | 14 | 95 | 4 | 11500849 | |
| Pubmed | 1.36e-07 | 298 | 95 | 9 | 30737378 | ||
| Pubmed | 2.03e-07 | 225 | 95 | 8 | 12168954 | ||
| Pubmed | 3.02e-07 | 21 | 95 | 4 | 19596656 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NHSL1 FAT1 TNRC18 IGF2R DST SLC37A3 TRIO KALRN MYCBP2 LAT2 LRBA PIP5K1C ANKRD33B TBC1D9 SPATA13 | 3.17e-07 | 1105 | 95 | 15 | 35748872 |
| Pubmed | 3.38e-07 | 332 | 95 | 9 | 37433992 | ||
| Pubmed | DST TRIO KALRN MYCBP2 KIF21A RNF10 KDM4A CHD4 SMARCAD1 LRBA RAPGEF2 CMYA5 UBASH3A GEN1 PCM1 ZNF292 | 3.89e-07 | 1285 | 95 | 16 | 35914814 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | PACS1 FAT1 IGF2R GPR158 FRMD7 PPP1R9A DOCK7 APLP2 PKN2 LRBA PACSIN2 | 4.61e-07 | 569 | 95 | 11 | 30639242 |
| Pubmed | DST RBBP6 FHOD1 APLP2 CCDC97 PRKCZ RAPGEF2 SLC4A4 LCP2 PACSIN2 | 9.06e-07 | 486 | 95 | 10 | 20936779 | |
| Pubmed | Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. | 1.09e-06 | 8 | 95 | 3 | 23254285 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.15e-06 | 283 | 95 | 8 | 30585729 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 2.34e-06 | 10 | 95 | 3 | 30595551 | |
| Pubmed | 3.35e-06 | 83 | 95 | 5 | 28794006 | ||
| Pubmed | 4.27e-06 | 12 | 95 | 3 | 16116422 | ||
| Pubmed | 7.03e-06 | 14 | 95 | 3 | 20347429 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29369481 | ||
| Pubmed | Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. | 7.38e-06 | 2 | 95 | 2 | 7560064 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 30297340 | ||
| Pubmed | Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. | 7.38e-06 | 2 | 95 | 2 | 18971343 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 7575689 | ||
| Pubmed | Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP. | 7.38e-06 | 2 | 95 | 2 | 26858404 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 23335746 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25238757 | ||
| Pubmed | Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene. | 7.38e-06 | 2 | 95 | 2 | 15172967 | |
| Pubmed | Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development. | 7.38e-06 | 2 | 95 | 2 | 35568926 | |
| Pubmed | Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. | 7.38e-06 | 2 | 95 | 2 | 8843877 | |
| Pubmed | 9.25e-06 | 268 | 95 | 7 | 33640491 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MRTFB DST RBBP6 FHOD1 DBNL RPRD2 PKN2 CHD3 CHD4 LRBA MED1 PCM1 | 9.28e-06 | 934 | 95 | 12 | 33916271 |
| Pubmed | 9.50e-06 | 634 | 95 | 10 | 34591612 | ||
| Pubmed | 9.69e-06 | 103 | 95 | 5 | 32744500 | ||
| Pubmed | 1.01e-05 | 503 | 95 | 9 | 16964243 | ||
| Pubmed | 1.06e-05 | 506 | 95 | 9 | 30890647 | ||
| Pubmed | 1.08e-05 | 16 | 95 | 3 | 20347428 | ||
| Pubmed | RAD51AP1 FAT1 ZFHX4 RBBP6 SUPT16H CHD3 CHD4 SMARCAD1 RAPGEF2 MDM2 TRIM24 TRIP4 PCM1 | 1.09e-05 | 1116 | 95 | 13 | 31753913 | |
| Pubmed | 1.10e-05 | 645 | 95 | 10 | 25281560 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BLM RAD51AP1 RBBP6 SUPT16H RPRD2 CHD3 CHD4 MED1 FANCM TRIM24 JMJD1C PCM1 | 1.15e-05 | 954 | 95 | 12 | 36373674 |
| Pubmed | 1.56e-05 | 18 | 95 | 3 | 22343915 | ||
| Pubmed | 1.56e-05 | 18 | 95 | 3 | 26209645 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | FBXO38 RAD51AP1 IGF2R MYCBP2 PPP1R9A SUPT16H DOCK7 MPDZ PKN2 KDM4A CHD4 COPS2 | 1.92e-05 | 1005 | 95 | 12 | 19615732 |
| Pubmed | Pooled-matrix protein interaction screens using Barcode Fusion Genetics. | 2.02e-05 | 419 | 95 | 8 | 27107012 | |
| Pubmed | Genetic susceptibility to distinct bladder cancer subphenotypes. | 2.09e-05 | 421 | 95 | 8 | 19692168 | |
| Pubmed | 2.18e-05 | 20 | 95 | 3 | 22705371 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 20606011 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 29620483 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 31801062 | ||
| Pubmed | FANCM, BRCA1, and BLM cooperatively resolve the replication stress at the ALT telomeres. | 2.21e-05 | 3 | 95 | 2 | 28673972 | |
| Pubmed | Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease. | 2.21e-05 | 3 | 95 | 2 | 29477871 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 9695949 | ||
| Pubmed | RB18A enhances expression of mutant p53 protein in human cells. | 2.21e-05 | 3 | 95 | 2 | 15848166 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 32658897 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 24458359 | ||
| Pubmed | PACT is a negative regulator of p53 and essential for cell growth and embryonic development. | 2.21e-05 | 3 | 95 | 2 | 17470788 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 27017521 | ||
| Pubmed | RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway. | 2.21e-05 | 3 | 95 | 2 | 25520194 | |
| Pubmed | Delineation of WRN helicase function with EXO1 in the replicational stress response. | 2.21e-05 | 3 | 95 | 2 | 20447876 | |
| Pubmed | Palmitoylation controls recycling in lysosomal sorting and trafficking. | 2.21e-05 | 3 | 95 | 2 | 18817523 | |
| Pubmed | RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis. | 2.21e-05 | 3 | 95 | 2 | 20595512 | |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 19268428 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 19556538 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 24440720 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.29e-05 | 123 | 95 | 5 | 26912792 | |
| Pubmed | 2.44e-05 | 209 | 95 | 6 | 36779422 | ||
| Pubmed | 2.45e-05 | 708 | 95 | 10 | 39231216 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.86e-05 | 440 | 95 | 8 | 34244565 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.96e-05 | 724 | 95 | 10 | 36232890 | |
| Pubmed | 3.01e-05 | 322 | 95 | 7 | 26514267 | ||
| Pubmed | 3.15e-05 | 446 | 95 | 8 | 24255178 | ||
| Pubmed | 3.33e-05 | 133 | 95 | 5 | 15144186 | ||
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 3.51e-05 | 223 | 95 | 6 | 33187986 | |
| Pubmed | CREBRF RAD51AP1 TNRC18 DST PHF20L1 KIF21A PPP1R9A DBNL SUPT16H DNAJC21 CHD3 CHD4 SPATA13 ZNF292 | 3.68e-05 | 1442 | 95 | 14 | 35575683 | |
| Pubmed | BTBD8 TRIO TAGAP DBNL DOCK7 MPDZ GIT2 PIP5K1C TRIP10 PACSIN2 SPATA13 | 4.15e-05 | 916 | 95 | 11 | 32203420 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.32e-05 | 341 | 95 | 7 | 32971831 | |
| Pubmed | BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites. | 4.41e-05 | 4 | 95 | 2 | 28912125 | |
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 31153714 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 16574654 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 9326634 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 23407547 | ||
| Pubmed | 4.41e-05 | 4 | 95 | 2 | 11781095 | ||
| Pubmed | A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo. | 4.41e-05 | 4 | 95 | 2 | 28892044 | |
| Pubmed | Recurrent activating mutations of PPARγ associated with luminal bladder tumors. | 4.41e-05 | 4 | 95 | 2 | 30651555 | |
| Pubmed | 4.70e-05 | 472 | 95 | 8 | 38943005 | ||
| Pubmed | 4.90e-05 | 26 | 95 | 3 | 23435420 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 4.91e-05 | 475 | 95 | 8 | 31040226 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | BLM DST MLX RBBP6 SUPT16H EXO1 RPRD2 CHD3 CHD4 MED1 RFX7 FANCM JMJD1C | 5.07e-05 | 1294 | 95 | 13 | 30804502 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PACS1 TNRC18 MRTFB TRIO MYCBP2 GPR158 PPP1R9A RPRD2 CHD3 PRKCZ LRBA RAPGEF2 JMJD1C PCM1 | 5.20e-05 | 1489 | 95 | 14 | 28611215 |
| Pubmed | 5.35e-05 | 777 | 95 | 10 | 35844135 | ||
| Pubmed | 5.76e-05 | 76 | 95 | 4 | 10574461 | ||
| Pubmed | NHSL1 TNRC18 TRIO KALRN MYCBP2 GPR158 DBNL USP24 DOCK7 RNF10 SLC4A4 PCM1 | 6.44e-05 | 1139 | 95 | 12 | 36417873 | |
| Pubmed | 6.76e-05 | 251 | 95 | 6 | 27507650 | ||
| Pubmed | 7.05e-05 | 80 | 95 | 4 | 16094384 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 30862798 | ||
| Pubmed | 7.34e-05 | 5 | 95 | 2 | 10764742 | ||
| Interaction | YWHAG interactions | NHSL1 PACS1 LNX2 KCNA3 DST MLX MYCBP2 DCP2 DBNL USP24 DOCK7 EXO1 MPDZ PKN2 PRKCZ GIT2 LRBA RAPGEF2 RFX7 GEN1 PCM1 SPATA13 | 4.71e-08 | 1248 | 94 | 22 | int:YWHAG |
| Interaction | RCOR1 interactions | MRTFB DST ZFHX4 MYCBP2 USP24 DOCK7 CHD3 CHD4 GIT2 LRBA TRIP4 JMJD1C PCM1 | 4.86e-07 | 494 | 94 | 13 | int:RCOR1 |
| Interaction | YWHAH interactions | NHSL1 PACS1 DST TRIO MYCBP2 DBNL DOCK7 RNF10 EXO1 MPDZ PRKCZ GIT2 LRBA MED1 RAPGEF2 RFX7 GEN1 PCM1 SPATA13 | 6.46e-07 | 1102 | 94 | 19 | int:YWHAH |
| Interaction | KDM1A interactions | MRTFB DST ZFHX4 PHF20L1 MYCBP2 SUPT16H USP24 DOCK7 RNF10 CHD3 CHD4 SMARCAD1 LRBA TRIM24 COPS2 JMJD1C PCM1 | 1.46e-06 | 941 | 94 | 17 | int:KDM1A |
| Interaction | PHF21A interactions | 4.56e-06 | 343 | 94 | 10 | int:PHF21A | |
| Interaction | NUP43 interactions | BLM MRTFB DST BTBD8 PHF20L1 RBBP6 DBNL SUPT16H CHD3 SMARCAD1 RAPGEF2 JMJD1C ZNF292 | 6.52e-06 | 625 | 94 | 13 | int:NUP43 |
| Interaction | H3-3A interactions | BLM FBXO38 RAD51AP1 PHF20L1 SUPT16H KDM4A CHD3 CHD4 SMARCAD1 MED1 TRIM24 COPS2 JMJD1C ZNF292 | 9.42e-06 | 749 | 94 | 14 | int:H3-3A |
| Interaction | HDAC1 interactions | TNRC18 MRTFB KCNA3 DST ZFHX4 PHF20L1 MYCBP2 USP24 DOCK7 KDM4A CHD3 CHD4 SMARCAD1 LRBA MDM2 JMJD1C PCM1 | 1.29e-05 | 1108 | 94 | 17 | int:HDAC1 |
| Interaction | RXRA interactions | 1.43e-05 | 169 | 94 | 7 | int:RXRA | |
| Interaction | H2BC21 interactions | BLM PPARGC1A MRTFB BTBD8 SUPT16H EXO1 DNAJC21 RPRD2 CHD4 MDM2 TRIM24 JMJD1C ZNF292 | 2.04e-05 | 696 | 94 | 13 | int:H2BC21 |
| Interaction | XRCC6 interactions | BLM TNRC18 MRTFB KCNA3 RBBP6 SUPT16H RPRD2 CHD3 CHD4 SMARCAD1 MED1 MDM2 TRIM24 TRIP4 JMJD1C | 2.44e-05 | 928 | 94 | 15 | int:XRCC6 |
| Interaction | WWTR1 interactions | 2.75e-05 | 422 | 94 | 10 | int:WWTR1 | |
| Interaction | RAC1 interactions | PACS1 FAT1 IGF2R DST TRIO KALRN FHOD1 PPP1R9A DOCK7 APLP2 NCF2 PKN2 GIT2 LRBA PIP5K1C PACSIN2 | 3.03e-05 | 1063 | 94 | 16 | int:RAC1 |
| Interaction | SIRT6 interactions | BLM FAT4 FAT1 MYCBP2 SUPT16H RPRD2 CHD3 CHD4 MED1 MDM2 TRIP10 TRIP4 | 3.50e-05 | 628 | 94 | 12 | int:SIRT6 |
| Interaction | SOX7 interactions | 4.07e-05 | 82 | 94 | 5 | int:SOX7 | |
| Interaction | MED4 interactions | 4.73e-05 | 450 | 94 | 10 | int:MED4 | |
| Interaction | UBE2I interactions | BLM PPARGC1A LNX2 MLX RBBP6 RNF10 EXO1 CHD3 CHD4 MDM2 FANCM TRIM24 | 5.18e-05 | 654 | 94 | 12 | int:UBE2I |
| Interaction | WAS interactions | 6.04e-05 | 89 | 94 | 5 | int:WAS | |
| Interaction | GSK3A interactions | 6.11e-05 | 464 | 94 | 10 | int:GSK3A | |
| Interaction | RHOF interactions | PACS1 FAT4 FAT1 IGF2R PPP1R9A SUPT16H DOCK7 MPDZ PKN2 GIT2 PIP5K1C PACSIN2 | 6.82e-05 | 673 | 94 | 12 | int:RHOF |
| Interaction | MEX3A interactions | 7.70e-05 | 384 | 94 | 9 | int:MEX3A | |
| Interaction | ZNF785 interactions | 8.25e-05 | 95 | 94 | 5 | int:ZNF785 | |
| Interaction | MB interactions | 9.02e-05 | 19 | 94 | 3 | int:MB | |
| Interaction | SUMO2 interactions | BLM FBXO38 DST KALRN SUPT16H PKN2 CHD3 CHD4 SMARCAD1 PRKCZ TRIM24 | 9.59e-05 | 591 | 94 | 11 | int:SUMO2 |
| Interaction | NRAS interactions | FAT1 IGF2R SLC37A3 GPR158 FHOD1 FRMD7 PPP1R9A DOCK7 APLP2 PKN2 GEN1 PACSIN2 | 9.76e-05 | 699 | 94 | 12 | int:NRAS |
| Interaction | H3C3 interactions | BLM FBXO38 SUPT16H CHD3 CHD4 SMARCAD1 MED1 TRIM24 JMJD1C ZNF292 | 1.04e-04 | 495 | 94 | 10 | int:H3C3 |
| Interaction | CSNK2A1 interactions | PACS1 ABCA1 IGF2R DST MLX SUPT16H USP24 RPRD2 CHD3 CHD4 SMARCAD1 PRKCZ MDM2 COPS2 | 1.34e-04 | 956 | 94 | 14 | int:CSNK2A1 |
| Interaction | TOP3B interactions | NHSL1 FAT1 TNRC18 IGF2R DST SLC37A3 TRIO KALRN MYCBP2 LAT2 PPP1R9A SUPT16H KDM4A LRBA PIP5K1C ANKRD33B TBC1D9 SPATA13 | 1.34e-04 | 1470 | 94 | 18 | int:TOP3B |
| Interaction | ABL2 interactions | 1.45e-04 | 107 | 94 | 5 | int:ABL2 | |
| Interaction | CDC5L interactions | DST TRIO KALRN RBBP6 FHOD1 KIF21A USP24 PKN2 CHD3 CHD4 SMARCAD1 CCDC97 COPS2 | 1.65e-04 | 855 | 94 | 13 | int:CDC5L |
| Interaction | RHOJ interactions | FAT1 IGF2R FHOD1 PPP1R9A SUPT16H USP24 PKN2 GIT2 PIP5K1C TRIP10 PACSIN2 | 1.75e-04 | 633 | 94 | 11 | int:RHOJ |
| Interaction | HDAC2 interactions | PHF20L1 TRIO MYCBP2 DNAJC21 RPRD2 CHD3 LTBP1 CHD4 SMARCAD1 GIT2 LRBA MDM2 JMJD1C | 1.85e-04 | 865 | 94 | 13 | int:HDAC2 |
| Interaction | AR interactions | TNRC18 MYCBP2 SUPT16H RPRD2 KDM4A CHD3 CHD4 MED1 MDM2 TRIM24 COPS2 TRIP4 JMJD1C PCM1 | 1.97e-04 | 992 | 94 | 14 | int:AR |
| Interaction | CBX3 interactions | BLM RAD51AP1 KCNA3 RBBP6 SUPT16H CHD3 CHD4 SMARCAD1 MED1 TRIM24 ZNF292 | 2.09e-04 | 646 | 94 | 11 | int:CBX3 |
| Interaction | CETN1 interactions | 2.14e-04 | 63 | 94 | 4 | int:CETN1 | |
| Interaction | TULP3 interactions | 2.15e-04 | 346 | 94 | 8 | int:TULP3 | |
| Interaction | FANCM interactions | 2.28e-04 | 64 | 94 | 4 | int:FANCM | |
| Interaction | FAAP24 interactions | 2.36e-04 | 26 | 94 | 3 | int:FAAP24 | |
| Interaction | THRB interactions | 2.37e-04 | 186 | 94 | 6 | int:THRB | |
| Interaction | CENPX interactions | 2.65e-04 | 27 | 94 | 3 | int:CENPX | |
| Interaction | MSH6 interactions | 2.78e-04 | 271 | 94 | 7 | int:MSH6 | |
| Interaction | KRT14 interactions | 2.81e-04 | 192 | 94 | 6 | int:KRT14 | |
| Interaction | VDR interactions | 3.22e-04 | 127 | 94 | 5 | int:VDR | |
| Interaction | TPR interactions | 3.46e-04 | 281 | 94 | 7 | int:TPR | |
| Interaction | MED17 interactions | 3.69e-04 | 202 | 94 | 6 | int:MED17 | |
| Interaction | YWHAZ interactions | NHSL1 PACS1 RAD51AP1 LNX2 DST MLX MYCBP2 FHOD1 DOCK7 EXO1 PRKCZ RAPGEF2 MDM2 LCP2 PCM1 SPATA13 | 3.71e-04 | 1319 | 94 | 16 | int:YWHAZ |
| Interaction | CDC42 interactions | FAT4 FAT1 ABCA1 IGF2R TRIO FHOD1 PPP1R9A DOCK7 NCF2 PKN2 PRKCZ GIT2 TRIP10 PCM1 PACSIN2 SPATA13 | 3.84e-04 | 1323 | 94 | 16 | int:CDC42 |
| Interaction | ZBBX interactions | 4.02e-04 | 31 | 94 | 3 | int:ZBBX | |
| Interaction | MED1 interactions | 4.09e-04 | 206 | 94 | 6 | int:MED1 | |
| GeneFamily | PHD finger proteins | 3.27e-04 | 90 | 66 | 4 | 88 | |
| GeneFamily | PHD finger proteins|NuRD complex | 8.46e-04 | 12 | 66 | 2 | 1305 | |
| GeneFamily | Cadherin related | 1.72e-03 | 17 | 66 | 2 | 24 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.80e-03 | 66 | 66 | 3 | 722 | |
| GeneFamily | PDZ domain containing | 2.31e-03 | 152 | 66 | 4 | 1220 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.39e-03 | 20 | 66 | 2 | 548 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 3.16e-03 | 23 | 66 | 2 | 1288 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.44e-03 | 24 | 66 | 2 | 485 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CREBRF PACS1 PHF20L1 MYCBP2 TAGAP RBBP6 FHOD1 DCP2 USP24 GBP3 CHD3 GIT2 LRBA MED1 RFX7 LCP2 UBASH3A JMJD1C PCM1 SPATA13 ZNF292 IFNAR2 | 1.32e-08 | 1492 | 95 | 22 | M40023 |
| Coexpression | GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP | 4.88e-08 | 200 | 95 | 9 | M5069 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | CREBRF ABCA1 ELL2 PHF20L1 RBBP6 RNF10 PKN2 RAPGEF2 ANKRD33B JMJD1C SPATA13 ZNF292 | 6.46e-06 | 680 | 95 | 12 | M41089 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CREBRF PACS1 PPARGC1A KCNA3 ZFHX4 MYCBP2 GPR158 KIF21A PPP1R9A CACNA1G CHD3 PRKCZ RFX7 TBC1D9 SPATA13 | 1.02e-05 | 1106 | 95 | 15 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | BLM FAT1 ELL2 IGF2R DST TRIO MYCBP2 USP24 PKN2 MED1 RAPGEF2 TRIM24 ZNF292 | 1.29e-05 | 856 | 95 | 13 | M4500 |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | 3.92e-05 | 172 | 95 | 6 | M8234 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 5.00e-05 | 466 | 95 | 9 | M13522 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | 7.93e-05 | 495 | 95 | 9 | M8451 | |
| Coexpression | GSE360_CTRL_VS_T_GONDII_DC_DN | 8.57e-05 | 198 | 95 | 6 | M5148 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN | 8.57e-05 | 198 | 95 | 6 | M5776 | |
| Coexpression | GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN | 8.81e-05 | 199 | 95 | 6 | M7782 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN | 8.81e-05 | 199 | 95 | 6 | M9501 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN | 8.81e-05 | 199 | 95 | 6 | M7463 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN | 8.81e-05 | 199 | 95 | 6 | M5682 | |
| Coexpression | GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN | 9.05e-05 | 200 | 95 | 6 | M6442 | |
| Coexpression | GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN | 9.05e-05 | 200 | 95 | 6 | M8518 | |
| Coexpression | GSE7852_LN_VS_THYMUS_TCONV_DN | 9.05e-05 | 200 | 95 | 6 | M5746 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 9.09e-05 | 504 | 95 | 9 | M2157 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 1.06e-04 | 206 | 95 | 6 | M39254 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BLM PPARGC1A RAD51AP1 PHF20L1 MYCBP2 SMARCAD1 FST TRIM24 PCM1 TBC1D9 | 1.35e-04 | 656 | 95 | 10 | M18979 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | CREBRF NHSL1 FANCB DST TRIO KALRN RBBP6 KIF21A DOCK7 CHD3 LTBP1 CHD4 GEN1 | 1.70e-04 | 1102 | 95 | 13 | M2369 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | BLM DDIAS RAD51AP1 ELL2 SUPT16H DOCK7 RNF10 EXO1 DNAJC21 CACNA1G CHD4 SMARCAD1 LRBA SLC4A4 FANCM TRIM24 COPS2 GEN1 PCM1 ZNF292 | 4.75e-07 | 1241 | 95 | 20 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.32e-06 | 311 | 95 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BLM RAD51AP1 RBBP6 KIF21A SUPT16H DOCK7 EXO1 DNAJC21 CHD4 SMARCAD1 DBR1 RAPGEF2 FANCM TRIM24 COPS2 GEN1 TRIP4 PCM1 ZNF292 | 2.50e-06 | 1257 | 95 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | BLM PPARGC1A RAD51AP1 KIF21A SUPT16H DOCK7 EXO1 DNAJC21 SMARCAD1 DBR1 FANCM TRIM24 GEN1 PCM1 TBC1D9 SPATA13 ZNF292 | 4.21e-06 | 1060 | 95 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | NHSL1 PPARGC1A FAT1 TNRC18 ELL2 DST ZFHX4 TAGAP KIF21A PPP1R9A SLC4A4 FST TRIM24 PACSIN2 IFNAR2 | 4.43e-06 | 837 | 95 | 15 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | BLM DDIAS RAD51AP1 ELL2 SUPT16H DOCK7 RNF10 EXO1 DNAJC21 CACNA1G CHD4 SMARCAD1 LRBA SLC4A4 FANCM TRIM24 COPS2 GEN1 PCM1 ZNF292 | 6.27e-06 | 1468 | 95 | 20 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | RAD51AP1 DST PHF20L1 SUPT16H EXO1 RAPGEF2 RFX7 FANCM TRIM24 GEN1 ZNF292 | 7.99e-06 | 469 | 95 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | FBXO38 DDIAS BTBD8 TRIO MYCBP2 USP24 RAPGEF2 FANCM TRIM24 JMJD1C PCM1 ZNF292 | 8.07e-06 | 564 | 95 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | BLM DDIAS RAD51AP1 LNX2 KIF21A SUPT16H DOCK7 DNAJC21 CACNA1G CHD4 SMARCAD1 LRBA FANCM TRIM24 COPS2 GEN1 PCM1 ZNF292 | 9.58e-06 | 1252 | 95 | 18 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | PPARGC1A ZDHHC15 FAT4 ABCA1 DST ZFHX4 TRIO KALRN MYCBP2 RBBP6 SUPT16H SLC4A4 FST ZNF292 | 1.36e-05 | 806 | 95 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BLM RAD51AP1 RBBP6 KIF21A SUPT16H DOCK7 EXO1 DNAJC21 CHD4 SMARCAD1 DBR1 RAPGEF2 FANCM TRIM24 COPS2 GEN1 TRIP4 PCM1 ZNF292 | 2.10e-05 | 1459 | 95 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d10.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 4.14e-05 | 369 | 95 | 9 | GSM605891_500 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | FAT4 TNRC18 ELL2 DST ZFHX4 TAGAP CHD3 FST TRIM24 F8 PACSIN2 ZNF292 IFNAR2 | 5.02e-05 | 791 | 95 | 13 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | BLM DDIAS PPARGC1A MRTFB IGF2R ZFHX4 KALRN TAGAP EXO1 MPDZ CACNA1G LTBP1 TRIM24 | 7.89e-05 | 827 | 95 | 13 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | DDIAS FAT4 MRTFB IGF2R ZFHX4 KALRN MPDZ CACNA1G CHD3 LTBP1 FST TRIM24 GEN1 | 8.28e-05 | 831 | 95 | 13 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3 | 8.46e-05 | 405 | 95 | 9 | GSM605796_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.10e-05 | 101 | 95 | 5 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k2 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 9.28e-05 | 410 | 95 | 9 | GSM538387_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BLM PPARGC1A LNX2 RBBP6 KIF21A SUPT16H EXO1 DNAJC21 LRBA FST GEN1 PCM1 SPATA13 ZNF292 | 1.25e-04 | 989 | 95 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | RAD51AP1 PHF20L1 KIF21A SUPT16H EXO1 SMARCAD1 RFX7 FANCM GEN1 TRIP4 | 1.34e-04 | 532 | 95 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000 | RAD51AP1 ABCA1 LNX2 TRIO MYCBP2 FHOD1 DCP2 NCF2 LCP2 F8 SPATA13 IFNAR2 | 1.53e-04 | 764 | 95 | 12 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | BLM PPARGC1A RAD51AP1 KIF21A SUPT16H DOCK7 EXO1 DNAJC21 SMARCAD1 DBR1 FANCM TRIM24 GEN1 PCM1 TBC1D9 SPATA13 ZNF292 | 1.62e-04 | 1414 | 95 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | FAT4 MRTFB ZFHX4 TAGAP DCP2 MPDZ CACNA1G LTBP1 SLC4A4 FST TRIM24 IFNAR2 | 1.92e-04 | 783 | 95 | 12 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.02e-04 | 268 | 95 | 7 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.52e-04 | 369 | 95 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d15.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 2.85e-04 | 376 | 95 | 8 | GSM605894_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d8.LisOva, CD8+ CD45.1+, Spleen, avg-3 | 3.06e-04 | 380 | 95 | 8 | GSM605901_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3 | 3.17e-04 | 382 | 95 | 8 | GSM476684_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PPARGC1A TRIO KIF21A USP24 RPRD2 CHD4 RAPGEF2 MDM2 TRIM24 ZNF292 | 3.30e-04 | 595 | 95 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 3.40e-04 | 386 | 95 | 8 | GSM605787_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3 | 3.52e-04 | 388 | 95 | 8 | GSM605790_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | CREBRF PPARGC1A RAD51AP1 FAT1 KIF21A DOCK7 EXO1 DNAJC21 SMARCAD1 FANCM TRIM24 GEN1 TRIP4 PCM1 TBC1D9 SPATA13 | 3.59e-04 | 1370 | 95 | 16 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 4.91e-04 | 408 | 95 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | 6.80e-04 | 328 | 95 | 7 | GSM605756_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500 | 7.14e-04 | 432 | 95 | 8 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 8.55e-04 | 247 | 95 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.34e-07 | 183 | 95 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Flowthrough-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-07 | 192 | 95 | 7 | 7a0ef1702d6538e5611cfdc633d8558f9523845c | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-07 | 192 | 95 | 7 | 05043fb75319b64f5ed7aee6a232309dcae891b8 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.93e-07 | 193 | 95 | 7 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.37e-07 | 199 | 95 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.37e-07 | 199 | 95 | 7 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 176 | 95 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-SCAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 180 | 95 | 6 | 6c70b6b7480507fa94625013222ad338ee7dd1d9 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-06 | 180 | 95 | 6 | c0c07937839652e01df10cc1e70aa005800ea6f6 | |
| ToppCell | LPS-IL1RA-Myeloid-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.44e-06 | 180 | 95 | 6 | 079c199425dd3c220f03c6dca1823946f07580a1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 184 | 95 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.77e-06 | 184 | 95 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 184 | 95 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-06 | 184 | 95 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 191 | 95 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 191 | 95 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.65e-06 | 193 | 95 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.65e-06 | 193 | 95 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 195 | 95 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 195 | 95 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.99e-06 | 196 | 95 | 6 | c9fb81a0578db6d278b8582d7b3add6c407e6dcf | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-06 | 199 | 95 | 6 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-06 | 199 | 95 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.35e-06 | 199 | 95 | 6 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.35e-06 | 199 | 95 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.48e-06 | 200 | 95 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.48e-06 | 200 | 95 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 4.48e-06 | 200 | 95 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.48e-06 | 200 | 95 | 6 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 2.85e-05 | 166 | 95 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 166 | 95 | 5 | 410843ad44f9b22d5476119ac0d7c9168e17ac4b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.29e-05 | 171 | 95 | 5 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.29e-05 | 171 | 95 | 5 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-05 | 174 | 95 | 5 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-05 | 174 | 95 | 5 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-05 | 174 | 95 | 5 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 3.67e-05 | 175 | 95 | 5 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | facs-Trachea-3m-Hematologic|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.87e-05 | 177 | 95 | 5 | c9d235fc518b291ed98088a1206d14d6692bc7fd | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-05 | 177 | 95 | 5 | 235254c08b44c20ee3cb62dd2ca0c7e46a2587e3 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC-cDC2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-05 | 177 | 95 | 5 | b59d9fcf0a4964ef2d6274b6021a69cf7d335e0a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-05 | 177 | 95 | 5 | f55332fe7fc32c23892ccf08b6b4d5b1ffcc0d3f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 178 | 95 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 178 | 95 | 5 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 4.09e-05 | 179 | 95 | 5 | 5f7e6670a0e906a0a5bc75735408361d88e78fa2 | |
| ToppCell | LPS_only-Myeloid-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-05 | 179 | 95 | 5 | d0a03e498afcfeb657037889685ecd77bed07e6c | |
| ToppCell | LPS_only-Myeloid-Neutrophils-Neutrophils|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-05 | 179 | 95 | 5 | d034651a5a355a58f5e15db627869f4feebdfe35 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-05 | 180 | 95 | 5 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.20e-05 | 180 | 95 | 5 | 407fd8f61a757626e082b6e2eefd3a33276e6b71 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-05 | 180 | 95 | 5 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-05 | 180 | 95 | 5 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.31e-05 | 181 | 95 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 182 | 95 | 5 | fbe5bdd642b86010dbef0a567b25c69c7335688f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.42e-05 | 182 | 95 | 5 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 183 | 95 | 5 | 262387ee8d43b96e5f1a77c75124459a506a6172 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.54e-05 | 183 | 95 | 5 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 183 | 95 | 5 | c85a707acbcb582912e8ac080a36d05f91cfd7a2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-05 | 185 | 95 | 5 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.78e-05 | 185 | 95 | 5 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 4.78e-05 | 185 | 95 | 5 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 185 | 95 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells-Pro-B|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.91e-05 | 186 | 95 | 5 | 4a5264e32ba004ed58dc4102d84e4bc4dbbe1440 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-B_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.91e-05 | 186 | 95 | 5 | 528ee88f6e27863c7bcdffd4416cbbd83fc65e9d | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 187 | 95 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 187 | 95 | 5 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.16e-05 | 188 | 95 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 188 | 95 | 5 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 189 | 95 | 5 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 5.43e-05 | 190 | 95 | 5 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 5.43e-05 | 190 | 95 | 5 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 5.56e-05 | 191 | 95 | 5 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 191 | 95 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | PSB-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.70e-05 | 192 | 95 | 5 | 8dbdaa6a81767a866fb856f99ae35f9ee8064106 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-05 | 192 | 95 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 193 | 95 | 5 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.84e-05 | 193 | 95 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 193 | 95 | 5 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 193 | 95 | 5 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-05 | 193 | 95 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 5.84e-05 | 193 | 95 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 193 | 95 | 5 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.84e-05 | 193 | 95 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | CF-Lymphoid|CF / Disease state, Lineage and Cell class | 5.84e-05 | 193 | 95 | 5 | 11de07d13a7da223990b56fa89ba7fc1c3dd0122 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 193 | 95 | 5 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 194 | 95 | 5 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 194 | 95 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 5.99e-05 | 194 | 95 | 5 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 194 | 95 | 5 | 590a9d4f054e6a3685daf752c9354650fcc7d18a | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.99e-05 | 194 | 95 | 5 | 08fad7591c20568de797cf8e206de2d0b1d78aab | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 5.99e-05 | 194 | 95 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 195 | 95 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 195 | 95 | 5 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 195 | 95 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 195 | 95 | 5 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.14e-05 | 195 | 95 | 5 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 195 | 95 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.29e-05 | 196 | 95 | 5 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.29e-05 | 196 | 95 | 5 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.29e-05 | 196 | 95 | 5 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.44e-05 | 197 | 95 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.44e-05 | 197 | 95 | 5 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| Drug | geldanamycin | FANCB ELL2 DST ZFHX4 SUPT16H RAPGEF2 RFX7 MDM2 FANCM JMJD1C PCM1 | 4.26e-07 | 371 | 95 | 11 | ctd:C001277 |
| Drug | 3-FLUOROSIALIC ACID | 3.96e-06 | 26 | 95 | 4 | CID005288256 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 2.13e-05 | 17 | 95 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Bone marrow hypocellularity | 2.55e-05 | 18 | 95 | 3 | C1855710 | |
| Disease | Pancytopenia | 7.97e-05 | 26 | 95 | 3 | C0030312 | |
| Disease | Acute monocytic leukemia | 7.97e-05 | 26 | 95 | 3 | C0023465 | |
| Disease | Miller Dieker syndrome | 1.11e-04 | 29 | 95 | 3 | C0265219 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 1.36e-04 | 31 | 95 | 3 | EFO_0022249 | |
| Disease | white matter volume measurement | 1.50e-04 | 32 | 95 | 3 | EFO_0008320 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 2.46e-04 | 94 | 95 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | triglycerides in large LDL measurement | 3.63e-04 | 43 | 95 | 3 | EFO_0022319 | |
| Disease | Malignant Head and Neck Neoplasm | 3.89e-04 | 44 | 95 | 3 | C0278996 | |
| Disease | triacylglycerol 54:1 measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0010419 | |
| Disease | Huntington's disease (is_marker_for) | 6.74e-04 | 53 | 95 | 3 | DOID:12858 (is_marker_for) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 7.71e-04 | 222 | 95 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | Common variable immunodeficiency | 7.82e-04 | 13 | 95 | 2 | cv:C0009447 | |
| Disease | triglycerides in LDL measurement | 7.92e-04 | 56 | 95 | 3 | EFO_0022320 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 8.19e-04 | 225 | 95 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio | 8.52e-04 | 227 | 95 | 5 | EFO_0020946 | |
| Disease | total lipids in VLDL measurement | 9.69e-04 | 60 | 95 | 3 | EFO_0022314 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.02e-03 | 137 | 95 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | triglycerides in medium LDL measurement | 1.07e-03 | 62 | 95 | 3 | EFO_0022322 | |
| Disease | cholesterol in large VLDL measurement | 1.22e-03 | 65 | 95 | 3 | EFO_0021902 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.33e-03 | 67 | 95 | 3 | C3463824 | |
| Disease | hyperglycemia (implicated_via_orthology) | 1.35e-03 | 17 | 95 | 2 | DOID:4195 (implicated_via_orthology) | |
| Disease | respiratory symptom change measurement, response to placebo | 1.35e-03 | 17 | 95 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.66e-03 | 264 | 95 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.07e-03 | 78 | 95 | 3 | EFO_0022187 | |
| Disease | red blood cell density measurement | 2.14e-03 | 880 | 95 | 9 | EFO_0007978 | |
| Disease | Lewy Body Disease | 2.27e-03 | 22 | 95 | 2 | C0752347 | |
| Disease | Leukemia, Myelocytic, Acute | 2.40e-03 | 173 | 95 | 4 | C0023467 | |
| Disease | Immunologic Deficiency Syndromes | 2.48e-03 | 23 | 95 | 2 | C0021051 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.48e-03 | 23 | 95 | 2 | OBA_2045158 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 2.54e-03 | 291 | 95 | 5 | EFO_0008317, EFO_0020946 | |
| Disease | waist circumference | 2.67e-03 | 429 | 95 | 6 | EFO_0004342 | |
| Disease | Fanconi Anemia | 2.93e-03 | 25 | 95 | 2 | C0015625 | |
| Disease | age at menarche | 3.11e-03 | 594 | 95 | 7 | EFO_0004703 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.20e-03 | 91 | 95 | 3 | EFO_0004611, EFO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVDSFSQNDSIYEDQ | 411 | O00472 | |
| SLVDSDDEDNFSYIP | 71 | Q9BXY5 | |
| YDLEYSEDSNSEPNV | 16 | P61201 | |
| ADTGISSEFYDNAND | 221 | P07357 | |
| SDTFSEPGYENDSVE | 401 | Q8IUR6 | |
| DVNDNSPVFLSDDYF | 3186 | Q6V0I7 | |
| EQYTFVSNDAPEDTG | 1386 | O95477 | |
| SVESQDNDQPDYDSV | 381 | Q14161 | |
| QDNFETDAVYDLPSS | 361 | Q8IU60 | |
| SIASDDSFYPFEDEE | 51 | A6NCL7 | |
| VNYSQFDHSDSDDDF | 11 | Q96B01 | |
| ADVNDNAPAFAQSEY | 446 | Q9Y5H5 | |
| SVPNTDDEDSDYHQE | 106 | Q9UH92 | |
| TNDVDVYFETSADDN | 371 | Q06481 | |
| DANDNSPVFESSPYE | 2801 | Q14517 | |
| FSYEATQPEDLEFQE | 466 | P19878 | |
| SNNPRDDIATEAYED | 671 | Q5T848 | |
| ENEDNTNRDSPIFDY | 2206 | Q03001 | |
| ENDETASPADVFYDV | 2436 | Q03001 | |
| EDSAFQPYQDDIDSL | 141 | Q15652 | |
| FSQIPEQDETYLEDS | 1591 | Q8IYD8 | |
| LDEEDEDAYFNTPTA | 686 | Q6ZUT3 | |
| EEQPSTFSENEYDAS | 566 | Q8N448 | |
| FDYSTVDDNPDFDNL | 301 | Q96F63 | |
| AANASPFCDDYQDED | 141 | Q5SYE7 | |
| ASASNLDDFYPAEED | 691 | Q15154 | |
| DALVDFSEQYTPEAD | 1591 | Q14766 | |
| SDSEYNFENSQDFVP | 756 | Q8IXT1 | |
| DDFEEVAQNTYTNAD | 581 | O60229 | |
| DYPHTQGDFSFDEDS | 166 | Q9ULH7 | |
| DEKDYPASTSQDSFE | 261 | P22001 | |
| SFSDNLYPEDIVSQD | 936 | O75164 | |
| SSELYFEVDEEDPNF | 2101 | P50851 | |
| NENEDSADFVSFFPD | 161 | Q9H0R5 | |
| FDIYDEDENQSPRSF | 1696 | P00451 | |
| EEEDEDQDYSFPISS | 326 | P19883 | |
| TEDDYGDDPSTNSFE | 171 | Q9BRR3 | |
| VDDFPTFGDSQSDYD | 131 | Q5F1R6 | |
| SPDIDNYSEEEEESF | 271 | Q6VY07 | |
| ETDEAAFEPDYNESD | 1631 | Q7Z6E9 | |
| AFEPDYNESDSESNV | 1636 | Q7Z6E9 | |
| YNYDDESDSDTEAAP | 316 | P48551 | |
| DVNDNAPAFAQSEYT | 446 | Q9Y5I2 | |
| NYSSEPSDCNEDDLF | 366 | Q8NB91 | |
| YADLDSNSDDFDPAS | 761 | Q9UBK2 | |
| PNSFARYDFEDDEES | 1116 | Q6PIJ6 | |
| QSQSSYNPFEDEDDT | 356 | Q9UNF0 | |
| YNPFEDEDDTGSTVS | 361 | Q9UNF0 | |
| ETQPSYDIDNFDIDD | 546 | P54132 | |
| QVFESDEAPDGNSYQ | 156 | Q96N67 | |
| PDSDSEAVYEFTQDA | 686 | O43497 | |
| EDSEFYENDSNLGQD | 416 | P15391 | |
| DQDNQSEYSVGSEEE | 1356 | Q12873 | |
| DDFISNDNYDLEPAS | 176 | Q5XKL5 | |
| SEEENEEFEAYSPAA | 631 | Q8N3K9 | |
| SYETAENEESCFPDS | 856 | Q17RS7 | |
| DVESNDSGEDQSEYN | 401 | Q9UK59 | |
| AALPDQDSFYDVTDA | 286 | Q9Y613 | |
| DNQSDYSVASEEGDE | 1361 | Q14839 | |
| SSQEKFYPDTSFQED | 816 | Q5VT52 | |
| DYQAADDTEISFDPE | 381 | Q9UJU6 | |
| EYFDESSQSGDNDDF | 881 | Q15648 | |
| GDEYNQDFDSTNFEE | 656 | A8MW92 | |
| SASPEEDEESEDYQN | 181 | Q9GZY6 | |
| YDESEDDASDTNPDF | 1676 | P11717 | |
| SSSSEPYEEDEFNDD | 211 | Q9H4L7 | |
| NDSAYDSNDPDVESN | 306 | Q8N103 | |
| QASDEEDAPATDIYF | 626 | O60331 | |
| YQAGESDTDSFEEDP | 281 | Q00987 | |
| QPNDEDASSDAYCFE | 4001 | O75592 | |
| EDVSNFDDEFTSEAP | 941 | Q16513 | |
| SEIEDETFNPSEDDY | 941 | Q9Y5B9 | |
| DINTFEQIDDYNPDT | 331 | Q9UQ84 | |
| SQDTPIYTEFDEDFE | 521 | Q15642 | |
| SALVDDNGSEEDFSY | 106 | Q96N96 | |
| YQSQGFSTEEDEDEQ | 1481 | Q9Y4G8 | |
| AAEEDFEPNQDSSFS | 2116 | O15417 | |
| DNKFSDDSDDDFVQP | 1021 | O15164 | |
| FYITDDPDDNADRSE | 2841 | Q86UP3 | |
| NDADLVDESTFESPY | 831 | O75970 | |
| DEYEPNYSIQDDSSV | 261 | Q8NCC5 | |
| DESDSESDEKANYQA | 631 | Q7Z4S6 | |
| QATISFYEDSDSEDE | 106 | Q5TAB7 | |
| SEDQDYTAHFADPDT | 191 | Q8N5U6 | |
| SDQDEPDSAFEATQY | 941 | Q6ZT07 | |
| YSTDFIVFNDNDGSD | 641 | O60281 | |
| VSQTNESYFPFDDEL | 771 | Q2KHR2 | |
| EQSSAENEAEFPFTD | 71 | Q6UX27 | |
| DDDTDNPDDSVFYQV | 1721 | Q9UPU5 | |
| SENYSDKSDIENADE | 61 | Q9Y6R1 | |
| QVIDDESDYFASDSN | 281 | Q15650 | |
| SNTDFDNIVDPDVYS | 476 | A8MT70 | |
| EDFEEVAQNTYTNAD | 611 | O75962 | |
| DNEDDNQDYPEGSSS | 316 | Q96MV8 | |
| DYIFVDPTQQDEASE | 301 | P57075 | |
| SVASDDSLYPFQDEE | 51 | A6NHS1 | |
| SSFEEDDYESPNDDQ | 106 | Q13094 | |
| DDYGLDNFDTQFTSE | 541 | Q05513 | |
| QDEEEDSDENSYYQP | 421 | Q9ULJ8 |